E. Champion

发表

Germ-Line Effects of a Mutator , mu 2 , in hsophi la melanogaster

J. M. Mason, E. Champion, Hookt, 2002 .

Design of an α-L-transfucosidase for the synthesis of fucosylated HMOs.

C. Tellier, Amélie Saumonneau, V. Tran, 2015, Glycobiology.

Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist.

J. Evans, A. Ford-hutchinson, J. Gauthier, 1995, Canadian journal of physiology and pharmacology.

Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571.

A. Ford-hutchinson, J. Gauthier, S. Léger, 1991, Canadian journal of physiology and pharmacology.

Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist.

A. Ford-hutchinson, J. Gauthier, S. Léger, 1989, Canadian journal of physiology and pharmacology.

L-648,051, sodium 4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)- propylsulfonyl]-gamma-oxo-benzenebutanoate: a leukotriene D4 receptor antagonist.

R. Young, D. Denis, D. Éthier, 1986, Canadian journal of physiology and pharmacology.

Leukotrienes and Asthma

R. Dixon, J. Metzger, D. Riendeau, 1992 .

L-648,051: an aerosol active leukotriene D4 receptor antagonist.

D. Denis, D. Éthier, A. Ford-hutchinson, 1987, Advances in prostaglandin, thromboxane, and leukotriene research.

L-649,923, Sodium (βS*, γR*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)-γ-hydroxy-β-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist

R. Young, D. Denis, A. Ford-hutchinson, 1986 .

The discovery of L-699,392, a novel potent and orally active leukotriene D4 receptor antagonist

R. Young, A. Ford-hutchinson, R. Gordon, 1994 .

The discovery of a new structural class of potent orally active leukotriene D4 antagonists

R. Young, P. Prasit, A. Ford-hutchinson, 1992 .

NK1 and NK2 receptors mediate tachykinin and resiniferatoxin-induced bronchospasm in guinea pigs.

I. Rodger, T. Jones, P. Masson, 1993, The American review of respiratory disease.

The apo structure of sucrose hydrolase from Xanthomonas campestris pv. campestris shows an open active-site groove.

J. Kastrup, M. Gajhede, M. Remaud-Siméon, 2009, Acta crystallographica. Section D, Biological crystallography.

Pharmacology of L-655,240 (3-[1-(4-chlorobenzyl)-5-fluoro-3-methyl-indol-2-yl]2,2-dimethylpro pan oic acid); a potent, selective thromboxane/prostaglandin endoperoxide antagonist.

D. Éthier, J. Evans, A. Ford-hutchinson, 1987, European journal of pharmacology.

Applying pairwise combinations of amino acid mutations for sorting out highly efficient glucosylation tools for chemo-enzymatic synthesis of bacterial oligosaccharides.

L. Mourey, S. Tranier, I. André, 2012, Journal of the American Chemical Society.

Novel efficient routes to indoxyl glycosides for monitoring glycosidase activities.

G. Dékány, J. Thiem, M. Hederos, 2013, Organic letters.

Stereoselective synthesis of some acetylenic analogues of leukotrienes A and D

R. Young, J. Gauthier, S. Léger, 1986 .

Development of a novel series of styrylquinoline compounds as high-affinity leukotriene D4 receptor antagonists: synthetic and structure-activity studies leading to the discovery of (+-)-3-[[[3-[2-(7-chloro-2-quinolinyl)-(E)-ethenyl]phenyl][[3- (dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic

J. Gauthier, S. Léger, R. Zamboni, 1992, Journal of medicinal chemistry.

Synthesis of L-Rhamnose and N -Acetyl-D-Glucosamine Derivatives Entering in the Composition of Bacterial Polysaccharides by Use of Glucansucrases

I. André, S. Morel, P. Monsan, 2009 .

Probing Substrate Promiscuity of Amylosucrase from Neisseria polysaccharea

I. André, S. Morel, M. Remaud-Siméon, 2013 .

A pH‐Based High‐Throughput Screening of Sucrose‐Utilizing Transglucosidases for the Development of Enzymatic Glucosylation Tools

I. André, S. Morel, P. Monsan, 2010 .

Design of alpha-transglucosidases of controlled specificity for programmed chemoenzymatic synthesis of antigenic oligosaccharides.

Magali Remaud-Siméon, Julien Boutet, Isabelle André, 2009, Journal of the American Chemical Society.

Stereospecific synthesis, assignment of absolute configuration, and biological activity of the enantiomers of 3-[[[3-[2-(7-chloroquinolin-2-yl)-(E)-ethenyl]phenyl] [[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acid, a potent and specific leukotriene D4 receptor antagonist.

A. Ford-hutchinson, J. Gauthier, K. Hoogsteen, 1990, Journal of medicinal chemistry.

Design of alpha-transglucosidases of controlled specificity for programmed chemoenzymatic synthesis of antigenic oligosaccharides.

I. André, S. Morel, P. Monsan, 2009, Journal of the American Chemical Society.